Department of Pharmacology, Faculty of Medicine, The National University of Malaysia (UKM), Jalan Raja Muda Abdul Aziz 50300 KL, Malaysia.
Curr Drug Targets. 2013 Dec;14(13):1542-51. doi: 10.2174/13894501113149990196.
Bone quality assessment is important in assessments of potential agents for the prevention and treatment of osteoporosis. Bone density, microarchitecture and strength are important determinants in osteoporotic study which are widely studied using Dual-Energy X-ray Absorptiometry (DXA), histomorphometry and radiological imaging techniques. In recent years, high resolution micro-CT has become feasible for in vitro or in vivo evaluation of bone architecture. Three-dimensional images of micro-CT reflected high correlations with the conventional histomorphometry and DXA. In comparison to other imaging techniques, micro-CT is the most effective tool in detecting early bone changes for fracture prediction and assessments of potential anti-osteoporotic agents. It is crucial to define an ideal setting with safe radiation doses and appropriate methods for image reconstruction and segmentation to obtain high resolution images. Micro-CT evaluation provides a better insight of bone structure as well as non-metric parameters such as connectivity density, structural model index (SMI) and degree of anisotropy (DA). This non- invasive imaging technique is also equipped with finite element analysis for evaluation of bone biomechanical strength. Micro-CT allows a compressive understanding of the relationships between bone density, microarchitecture and strength which is fundamental to development of pharmacological interventions.
骨质量评估在评估潜在的骨质疏松预防和治疗药物中非常重要。骨密度、微结构和强度是骨质疏松研究中的重要决定因素,这些因素广泛应用于双能 X 射线吸收法(DXA)、组织形态计量学和影像学技术的研究。近年来,高分辨率微计算机断层扫描(micro-CT)已可用于体外或体内评估骨结构。micro-CT 的三维图像与传统的组织形态计量学和 DXA 具有高度相关性。与其他影像学技术相比,micro-CT 是检测早期骨变化、预测骨折和评估潜在抗骨质疏松药物的最有效工具。确定具有安全辐射剂量的理想设置以及适当的图像重建和分割方法以获得高分辨率图像至关重要。micro-CT 评估提供了对骨结构以及连通密度、结构模型指数(SMI)和各向异性程度(DA)等非计量参数的更好了解。这种非侵入性成像技术还配备了有限元分析,用于评估骨生物力学强度。micro-CT 允许对骨密度、微结构和强度之间的关系进行压缩理解,这是药物干预发展的基础。